Linux Laboratories Secures $70 Million Investment
Linux Laboratories, a pharmaceutical company based in Chennai, Tamil Nadu, has raised $70 million in a funding round led by ChrysCapital, with participation from Tata Capital Healthcare Fund III. The company is known for developing world-class medicines at affordable prices, aiming to make healthcare accessible to a broader population.
Funding Details
The investment comprises a mix of primary capital and a secondary purchase, with ChrysCapital acquiring a significant minority stake in the company. Tata Capital Healthcare Fund III continues its involvement with Linux Laboratories, following the exit of Tata Capital Healthcare Fund II, which reportedly achieved approximately four times return on its investment.
Leadership
The company was founded by Keerthivasan K and Parameswaran Hariharan, who both serve as Directors. Reflecting on the investment, S Ananda Kumar, co-founder and executive director of Linux Laboratories, stated, "ChrysCapital and Tata Capital Healthcare Fund III bring the sector experience and capital to take our vision into a much larger business."
Planned Use of Funds
Linux Laboratories plans to use the newly acquired funds to expand its presence in core and adjacent therapeutic areas. Further investments will be made in manufacturing and research and development capabilities. The company also intends to acquire pharmaceutical brands as part of its growth strategy.
Conclusion
This funding round is a significant step for Linux Laboratories as it aims to enhance its product offerings and strengthen its position in the pharmaceutical industry. With the backing of prominent investors like ChrysCapital and Tata Capital Healthcare Fund III, the company is well-positioned to pursue its expansion plans.